Genetic Analysis

Steatotic Liver Disease: From Causes to Cancer Therapies
Research & Development Steatotic Liver Disease: From Causes to Cancer Therapies

Steatotic liver disease (SLD), encompassing conditions like metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and their overlap (MetALD), has emerged as a dominant global health concern, affecting over 30% of adults worldwide. With its alarming

Mapping Resistance Mutations in Acinetobacter Baumannii
Tech & Innovation Mapping Resistance Mutations in Acinetobacter Baumannii

In hospital wards across the United States, a silent threat looms large, with over 1% of patients battling infections caused by Acinetobacter baumannii , a bacterium notorious for its ability to resist multiple antibiotics. This pathogen, often linked to severe outcomes like prolonged hospital

Can Genetic Testing Prevent Heart Attacks and Strokes?
Research & Development Can Genetic Testing Prevent Heart Attacks and Strokes?

Every year, millions of lives are cut short or forever altered by heart attacks and strokes, which stand as the leading causes of death across the globe, often striking with little to no warning, leaving families grappling with loss and survivors facing long, challenging recoveries. However,

Safer Treatment Paths for Kids with Medulloblastoma Unveiled
Research & Development Safer Treatment Paths for Kids with Medulloblastoma Unveiled

Every year, hundreds of children are diagnosed with medulloblastoma, a highly aggressive brain tumor that ranks as one of the most common malignant brain cancers in pediatric patients, leaving families grappling with not only the fear of survival but also the long-term consequences of harsh

How Do Early and Late Autism Diagnoses Differ Genetically?
Research & Development How Do Early and Late Autism Diagnoses Differ Genetically?

Autism Spectrum Disorder (ASD) has traditionally been understood as a condition manifesting in early childhood, yet a pioneering study from the University of Cambridge is turning this perspective on its head with revelations about the genetic and developmental differences tied to the timing of

PTGES3 Emerges as Key Target in Prostate Cancer Treatment
Research & Development PTGES3 Emerges as Key Target in Prostate Cancer Treatment

In a significant leap forward for prostate cancer research, a recent study published in Nature Genetics on November 5 has spotlighted PTGES3 (Prostaglandin E Synthase 3) as a pivotal regulator of the androgen receptor (AR), a protein deeply implicated in the disease’s progression. Conducted by

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later